ClinicalTrials.gg
RecruitingNCT07719660WBPMCSUpdated Aug 26, 2026

Wearable Blood-Pressure Monitoring Comparison Study

An observational study in Hypertension, Blood Pressure Monitoring and Wearable Devices, sponsored by Technische Universität Dresden. Recruiting at 2 sites in 2 countries. Open to participants aged 21 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Technische Universität Dresden · Observational

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
21 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 282 studies in Hypertension with a site in Germany — 29 open to participants now, 46 under way, 11 of them phase 3. Hypertension · Germany.

Planned enrollment
15th of 30
120 · median 120
Started
2026
with 4 others
Observational
31 of 282
8 open now
Primary completion
2027-07
later than 29 of 45 live
Registered
280th of 282
by date

Among the 282 studies in Hypertension with a site in Germany, this one is the 15th largest by planned enrollment of the 30 observational ones that give a count, is one of 5 that started in 2026, is one of 31 observational ones, reaches primary completion later than 29 of the 45 other live ones, and was the 280th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

29 of the 282 studies in Hypertension with a site in Germany are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 21 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 282 studies in Hypertension with a site in Germany, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare the accuracy, clinical applicability, and usability of different wearable blood pressure monitoring methods integrated in wearable devices, such as smartwatches, in hospitalized patients. The study evaluates novel photoplethysmography (PPG)-based and wrist-oscillometric blood pressure measurement methods against established clinical reference methods (upper-arm cuff measurements on the general ward and invasive arterial blood pressure monitoring (A-line) in the intensive care unit).

The main questions the study aims to answer are:

  • Can novel blood pressure monitoring methods suitable for integration into wearable devices achieve clinically acceptable agreement with established reference measurements?
  • How does the performance of calibration-dependent wearable devices change over time following calibration?
  • How does the performance of the investigated methods compare with each other?
  • How do the investigated methods perform for patients with different pre-existing conditions ?

To answer these questions, participants will undergo:

  • blood pressure measurements using different wearable devices based on PPG and wrist oscillometry
  • standardized reference blood pressure measurements using an upper-arm cuff (general ward) or an existing invasive arterial line (intensive care unit)
  • repeated measurements over three consecutive days on the general ward to assess calibration stability and measurement reproducibility,
03

Conditions studied

  • Hypertension
  • Blood Pressure Monitoring
  • Wearable Devices
  • Photoplethysmography
  • Cuff

Browse trials for

04

Who can participate

Ages eligible
21 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Hospitalized adult patients aged 21 to 85 years who are treated on participating general wards or intensive care units at the hospital and are able to provide written informed consent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Blood pressure measurements can be performed on at least one arm, for example no amputation, dialysis shunt, or obstructive dressing
  • Ability to understand the study information and provide written
  • For participants in the intensive care unit: an arterial line placed for clinical reasons

Exclusion criteria

Exclusion Criteria:

  • Wrist circumference exceeds the size range of the investigated wearable devices
  • Physical or medical conditions preventing placement of the wearable devices, including relevant skin lesions, wounds, severe edema, or patient restraint
  • Inability to provide written
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Cohort at general ward
  • Cohort at ICU
06

What researchers measure

Primary outcomes

  1. Agreement of wearable blood pressure measurement methods with clinical reference measurements

    The mean difference and standard deviation of the differences in systolic and diastolic blood pressure, expressed in mmHg, between each investigated wearable blood pressure measurement method and the corresponding reference method.

    Time frame: General ward: At each measurement session on study days 1, 2, and 3. ICU: At measurement session on study day 1, approx. 2 hours after device calibration

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — We plan to provide the anonymized IPD after publication.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: after finishing the study, data will be stored locally for at least 10 years

Access criteria: contact the investigators via mail

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jul 2027, 12 months after the start.

Of 348 non-industry observational studies under Hypertension, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 111. This study's planned 12 months is below that.

Counting every sponsor, half of 429 studies reached it within 38 months; a quarter within 17 and three quarters within 96.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2026
First posted
Jul 22, 2026
StartActual
Jul 20, 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07719660
Collaborators
Careggi Hospital
Responsible party
Moritz Herzog (Principal Investigator, Technische Universität Dresden) — Principal investigator
First posted
Jul 22, 2026
Start date
Jul 20, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 26, 2026

Study contacts

Moritz Herzog, MD
Contact
moritz.herzog@ukdd.de
0049 351 458 11501

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion